Skip to main content
. 2010 Aug 11;84(20):10630–10643. doi: 10.1128/JVI.01190-10

TABLE 5.

Summary of MAb binding to DENV-3 DIII variants expressed on the surfaces of yeast cellsa

MAb % of control value for variant with:
L301T S302N S303A V305G L306G K308E E309K K325E D328G D328N A329G A329T A329V P330G G340N A384Q K386E K386N L385A W389G W391A
DENV-3-E77 87.0 102.6 94.5 98.4 19.6 123.9 101.1 93.8 89.9 93.3 2.4 95.9 94.4 0.4 91.9 67.0 95.0 60.6 23.6 50.7 78.5
DENV-3-E61 111.2 104.5 94.5 62.9 1.4 15.8 16.0 49.1 1.1 1.6 2.4 87.6 116.7 1.3 105.8 72.3 75.6 77.2 2.3 8.3 27.8
DENV-3-E48 80.1 80.1 55.2 64.5 4.2 95.0 70.7 61.6 3.6 1.3 6.3 84.7 61.7 2.3 54.3 106.9 0.9 86.8 4.9 71.2 52.7
DENV-3-E47 123.0 8.5 90.2 93.9 10.4 107.5 88.4 71.7 1.5 1.9 17.9 95.9 103.1 9.6 101.7 100.0 60.7 91.2 32.6 88.6 84.9
DENV-3-E50 112.4 102.6 84.7 97.1 51.3 120.0 91.7 67.9 3.3 2.5 13.7 83.5 100.6 4.8 87.9 102.0 5.6 99.1 53.9 93.2 67.7
DENV-3-E51 80.7 98.1 66.1 93.1 18.6 112.5 86.2 67.9 3.3 3.5 6.2 80.6 58.0 3.0 52.6 88.1 1.7 92.1 27.4 87.7 72.0
DENV-3-E49 98.1 96.8 85.8 98.8 28.3 111.3 99.4 113.2 16.4 27.3 56.2 84.7 91.4 6.1 90.2 103.0 2.7 97.4 44.7 97.7 78.5
DENV-3-E54 118.3 133.7 106.6 93.9 41.6 103.8 91.7 65.4 6.8 19.1 4.8 116.5 102.8 3.9 111.8 104.0 2.8 98.2 51.1 90.4 71.0
DENV-3-E53 93.2 3.3 106.6 76.7 4.6 92.5 84.0 54.1 4.2 2.7 33.8 115.6 100.0 1.9 105.8 79.2 43.8 83.3 13.6 71.2 58.1
DENV-3-E57 120.5 97.4 86.9 80.0 11.5 97.5 80.7 65.4 16.4 23.7 4.8 75.3 106.8 2.2 80.9 96.0 1.3 89.5 32.9 84.9 73.1
DENV-3-E56 123.0 57.7 95.1 84.1 2.5 93.8 79.6 54.1 0.2 0.3 3.1 81.8 110.5 1.3 97.1 80.2 57.7 91.2 17.1 76.7 66.7
DENV-3-E58 113.0 0.8 88.0 79.2 2.6 88.8 79.6 57.9 0.6 0.2 2.6 78.8 109.9 2.0 84.4 83.2 53.7 89.5 15.4 74.0 64.5
DENV-3-E59 101.9 96.8 86.9 70.2 1.7 85.0 69.6 49.1 1.7 1.4 3.4 75.9 95.7 1.3 94.2 76.2 0.7 79.8 5.1 67.6 60.2
DENV-3-E60 100.0 92.3 76.0 92.2 17.6 103.8 82.9 55.3 15.1 18.6 10.3 74.1 86.4 1.7 78.6 86.1 2.6 85.1 36.5 86.8 73.1
DENV-3-E62 118.0 92.9 95.1 75.1 22.1 91.3 81.8 60.4 18.7 23.7 4.8 78.8 96.3 3.0 85.5 87.1 2.3 88.6 31.1 84.0 66.7
DENV-3-E63 105.0 94.2 90.2 84.1 10.5 86.3 65.2 49.1 19.3 25.3 4.9 72.9 110.5 1.3 91.9 93.1 1.1 83.3 22.8 76.7 55.9
DENV-3-E64 114.3 0.9 86.9 50.6 1.2 80.0 50.8 32.7 3.7 0.5 2.4 70.6 74.7 1.0 69.4 75.2 1.0 82.5 3.7 59.4 61.3
DENV-3-E67 99.4 84.0 84.2 97.1 6.0 95.0 87.3 52.8 1.2 3.7 2.6 74.7 92.6 1.4 78.6 91.1 0.4 88.6 35.6 79.5 67.7
DENV-3-E1 100 115 111 104 104 102 106 115 115 94 102 69 105 120 0.5 106 118 93 111 98 111
DENV-3-E84 89.4 93.6 94.5 24.8 0.1 83.4 39.6 56.8 0.1 0.1 0.2 90.6 80.2 0.1 0.1 57.1 75.2 41.6 0.1 0.1 10.1
DENV-3-E97 92.5 103.8 101.6 35.5 0.4 96.9 50.5 77.8 0.2 0.3 0.4 99.4 95.1 0.4 0.2 66.0 85.1 59.7 0.2 5.0 52.7
DENV-3-E98 105.6 99.3 107.6 58.1 0.4 79.8 71.4 67.9 7.6 0.4 10.3 ND ND 13.4 102.4 85.7 94.1 77.9 0.4 37.0 78.5
WNV E111 94 69 26 2 60 15 35 2 2 4 4 7 92 50 68.3 58 82 2 4 9 10
a

Staining of yeast cells that express DENV-3 16652 DIII with single point mutations. Yeast cells were stained with 20 μg/ml of MAb. Data represent the averages of results from four to six independent experiments. Data are normalized to the percentage of cells that stained positive for DENV-3-E8. Boldface indicates that the level of binding of a given MAb was from 0 to 25% of the control value, and underlining indicates that the level of binding was from 26 to 50% of the control value.